⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EXOZ News
eXoZymes Inc. Common Stock
eXoZymes Announces Graduation from Shell GameChanger(TM) Accelerator Powered by NLR (GCxN) Program
accessnewswire.com
EXOZ
Form 8-K
sec.gov
EXOZ
Form 8-K
sec.gov
EXOZ
eXoZymes CCO, Damien Perriman, Outlines NCTx Strategy and the Commercial Path for Cell-Free Biomanufacturing on Grow Everything Podcast
accessnewswire.com
EXOZ
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
accessnewswire.com
EXOZ
Form 8-K
sec.gov
EXOZ
eXoZymes to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday March 31, 2026
accessnewswire.com
EXOZ
Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability
accessnewswire.com
EXOZ
eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium
accessnewswire.com
EXOZ
With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation
accessnewswire.com
EXOZ